Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

132 Results Found

DEA proposes reducing five opioid production quotas for 2020

The Drug Enforcement Administration this week proposed reducing aggregate production quotas for five opioid controlled substances in 2020.

Survey: Drug shortages cost hospitals $360M annually

Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.

CDC anticipates shortage of TB screening test

The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug Administration.

Compounders prohibited from making, distributing certain drugs

A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company complies with federal law and other requirements, the Food and Drug Administration announced.

FDA releases final guidance on interchangeable biological products

The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a brand name biological product.

CREATES Act, other bills to boost generic competition advance in House

The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).

Civica Rx opens Utah headquarters

Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.

Hospitals, health systems launch not-for-profit generic drug company

Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications.

FDA to issue revised draft guidance on hospital pharmacy compounding

The Food and Drug Administration plans to revise its 2016 draft compounding guidance for hospital and health system pharmacies.
Public

Value Initiative Members In Action: Sutter Health – Sacramento, CA

Sutter Health, located in northern California, uses an artificial intelligence platform to reduce inpatient drug spending, decrease lengths of stay and improve quality and safety. Click the resource below to learn more